DE1436140U - - Google Patents

Info

Publication number
DE1436140U
DE1436140U DENDAT1436140D DE1436140DU DE1436140U DE 1436140 U DE1436140 U DE 1436140U DE NDAT1436140 D DENDAT1436140 D DE NDAT1436140D DE 1436140D U DE1436140D U DE 1436140DU DE 1436140 U DE1436140 U DE 1436140U
Authority
DE
Germany
Prior art keywords
ird
velrlngdrt
ufdßsum
uchsun
tteprfiche
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1436140D
Other languages
German (de)
English (en)
Publication of DE1436140U publication Critical patent/DE1436140U/de
Active legal-status Critical Current

Links

Landscapes

  • Hybrid Cells (AREA)
  • Primary Cells (AREA)
DENDAT1436140D Active DE1436140U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1436140U true DE1436140U (cg-RX-API-DMAC7.html)

Family

ID=744865

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1436140D Active DE1436140U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1436140U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
Laurence et al. Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2
AU691504B2 (en) Immunologic enhancement with intermittent interleukin-2 therapy
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Redding et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis
Krown et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study
DE1436140U (cg-RX-API-DMAC7.html)
US5696079A (en) Immunologic enhancement with intermittent interleukin-2 therapy
SPERBER et al. Anti-HIV-1 activity of recombinant and hybrid species of interferon-α
CN1281623C (zh) 抗病毒活性的人α干扰素衍生物
CN1943564A (zh) 吲达帕胺缓释片及其制备方法
WO2019107986A1 (ko) 피마살탄을 포함하는 약학적 조성물
CN213197198U (zh) 一种用于钢结构加工的夹紧设备
OHASHI et al. Effects of interferon-α on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells
Nishida et al. Grain Size Effect on Mechanical Strength of MgO-ZrO2 Composite Ceramics
DE1409138U (cg-RX-API-DMAC7.html)
AP132A (en) Improved formulation of low-dose interferon alpha.
CN109112438A (zh) 一种钛合金复合牙科用材料及其制备方法
DE1308148U (cg-RX-API-DMAC7.html)
Chuenchitra et al. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression
Gigout et al. Consequences of ddI-induced reduction of acute SIVmac251 virus load on cytokine profiles in cynomolgus macaques
DE1354641U (cg-RX-API-DMAC7.html)
Yamauchi et al. Dynamic Fatigue Behavior of Ceramics at Elevated Temperatures
CN1166318A (zh) 盐酸万乃洛韦及其药物组合物治疗乙型肝炎的用途
Levitz Host-fungal interactions in HIV infection
CN100339076C (zh) 吲达帕胺滴丸